Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Dermatology · Pemphigus Herpetiformis

The Biology of Your Skin: Why Pemphigus Herpetiformis Is Unique

At a Glance

Pemphigus herpetiformis is an autoimmune blistering disease in which antibodies disrupt connections between skin cells. Its itchy, inflamed rash can mimic other conditions, so doctors combine antibody tests, biopsy findings, and direct immunofluorescence to confirm the diagnosis and guide treatment.

To understand Pemphigus Herpetiformis (PH), it helps to think of your skin as a brick wall. In healthy skin, cell-junction structures called desmosomes hold the skin cells (the bricks) tightly together [1]. In PH, your immune system mistakenly produces autoantibodies—proteins that act like “anti-glue”—which attack the adhesion proteins within these structures, causing the skin cells to fall apart [1][2].

While this sounds like other forms of pemphigus, PH has a unique biological “signature” that explains why it looks and feels different from its more common relatives.

The Molecular Targets: Dsg and Dsc

The adhesion proteins targeted in PH are members of the cadherin family. Your immune system primarily targets two types:

  • Desmogleins (Dsg1 and Dsg3): Most people with PH have antibodies against Dsg1, which is found in the upper layers of the skin [3]. This explains why PH rarely affects the mouth (where Dsg3 is more common) [4]. Patients can also have anti-Dsg3 antibodies, or both.
  • Desmocollins (Dsc1, Dsc2, and Dsc3): This is where PH gets interesting. Unlike other types of pemphigus, PH can sometimes involve antibodies against desmocollins in a subset of cases [5]. Some patients have negative tests for Dsg1 and Dsg3 but test positive for Dsc3 [6]. While desmocollin antibodies are a possible but less-established pattern, they have been reported in atypical pemphigus, though this testing is not routinely available [7].

Why PH Mimics Other Diseases

The reason PH is so often misdiagnosed is that the initial biological reaction in the skin is very inflammatory. When the antibodies attack, they often trigger eosinophilic spongiosis—a state where fluid builds up between epidermal cells accompanied by eosinophils (a type of white blood cell) [2][8]. This inflammation is what causes the intense itching that makes PH look like a common allergy or a different blistering disease [9].

Comparing the “Look-Alikes”

Because PH can look like several other conditions, doctors must use specific tests to tell them apart. A positive DIF test supports a diagnosis of pemphigus, but confirming the herpetiform variant requires correlation with clinical and histologic patterns.

Condition Primary Target (Antibody) Where the Blister Forms Key Diagnostic Finding
Pemphigus Herpetiformis Dsg1, Dsg3 (sometimes Desmocollins) Inside the top layer of skin (Intraepidermal) [9] “Fish-net” pattern of IgG antibodies between skin cells [9]
Dermatitis Herpetiformis Transglutaminase 3 Beneath the top layer (Subepidermal) [10] Granular IgA deposits; strongly linked to celiac disease [11][12]
Bullous Pemphigoid BP180 and BP230 Beneath the top layer (Subepidermal) [13] Linear IgG and C3 proteins along the base of the skin layer [10]
Linear IgA Disease Various proteins Beneath the top layer (Subepidermal) [14] A solid “line” of IgA antibodies at the skin junction [14]

Why the Correct Name Matters

Getting the right diagnosis isn’t just about labels; it fundamentally changes your treatment plan. For example, if you were misdiagnosed with Dermatitis Herpetiformis, a gluten-free diet is indicated—but this is not a treatment for PH itself, though you should discuss celiac testing or diet changes with your clinician [11].

Similarly, while many of these conditions respond to a medication called dapsone, PH often requires a combination of dapsone and systemic corticosteroids (like prednisone) to fully stop the immune system’s attack on your skin’s adhesion proteins [2][3]. Distinguishing PH from its mimics ensures you aren’t over-treated with unnecessary drugs or under-treated for a condition that can become widespread [15]. Your doctor uses Direct Immunofluorescence (DIF) to look for that specific fish-net pattern of antibodies to support that you have a pemphigus variant [9][11].

Common questions in this guide

Which antibodies are tested in pemphigus herpetiformis?
Most people with pemphigus herpetiformis have antibodies against desmoglein 1, while some have desmoglein 3 antibodies or both. A subset has antibodies against desmocollins, such as Dsc3, especially when desmoglein tests are negative; specialized desmocollin testing is not routinely available.
What does a direct immunofluorescence test show in pemphigus herpetiformis?
Direct immunofluorescence often supports the diagnosis by showing IgG antibodies in a net-like pattern between skin cells. Doctors interpret this result together with the rash and biopsy findings because the test alone does not establish the herpetiform variant.
How is pemphigus herpetiformis distinguished from similar blistering diseases?
Doctors compare where the split occurs in the skin, which antibodies are present, and what the direct immunofluorescence test shows. Pemphigus herpetiformis usually forms a blister within the top skin layer and shows intercellular IgG, while dermatitis herpetiformis, bullous pemphigoid, and linear IgA disease form blisters beneath it and have different antibody patterns. The clinical appearance and biopsy findings are also important.
Why does pemphigus herpetiformis cause intense itching?
The antibody attack can trigger eosinophilic spongiosis, in which fluid and eosinophils collect between skin cells. This inflammatory reaction causes intense itching and can make pemphigus herpetiformis resemble an allergy or another blistering disease.
What treatments are used for pemphigus herpetiformis?
Treatment may include dapsone and systemic corticosteroids such as prednisone to control the immune attack on the skin. The exact plan depends on the diagnosis, severity, and response; a gluten-free diet is used for dermatitis herpetiformis linked to celiac disease, not as a treatment for pemphigus herpetiformis itself.
Does pemphigus herpetiformis affect the mouth?
Pemphigus herpetiformis usually targets desmoglein 1, which is more prominent in the upper skin layers, so mouth involvement is uncommon. Some people have desmoglein 3 antibodies or both desmoglein 1 and 3 antibodies, so any mouth sores or other mucosal symptoms should be reported to a clinician.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which specific autoantibodies were detected in my blood work—desmoglein 1, desmoglein 3, or desmocollins?
  2. 2.Did my biopsy show 'eosinophilic spongiosis' or 'acantholysis,' and how do those findings confirm it is pemphigus rather than another condition?
  3. 3.If my desmoglein tests were negative, were desmocollin antibodies or other specialized tests used to confirm my diagnosis?
  4. 4.How does my antibody profile (e.g., anti-Dsg1 versus anti-Dsg3) influence the expected course of my disease?
  5. 5.Can you explain the specific results of my Direct Immunofluorescence (DIF) test and whether it showed the 'fish-net' IgG pattern?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Comprehensive review on the pathophysiology, clinical variants and management of pemphigus (Review).

    Costan VV, Popa C, Hâncu MF, et al.

    Experimental and therapeutic medicine 2021; (22(5)):1335 doi:10.3892/etm.2021.10770.

    PMID: 34630689
  2. 2

    Pemphigus herpetiformis: a case series and review of the literature.

    Laws PM, Heelan K, Al-Mohammedi F, et al.

    International journal of dermatology 2015; (54(9)):1014-22 doi:10.1111/ijd.12582.

    PMID: 25600350
  3. 3

    Pemphigus herpetiformis in South Tunisia: a clinical expression of pemphigus foliaceus?

    Jerbi A, Hachicha H, Feki S, et al.

    International journal of dermatology 2018; (57(9)):1094-1101 doi:10.1111/ijd.14139.

    PMID: 30011065
  4. 4

    Pemphigus Herpetiformis Presenting With Mucosal Involvement: A Rare Clinical Presentation.

    Mayouf H, Alkandari D, Hussin M, Alajmi FM

    Cureus 2026; (18(4)):e106446 doi:10.7759/cureus.106446.

    PMID: 42093787
  5. 5

    Anti-desmocollin autoantibodies in nonclassical pemphigus.

    Ishii N, Teye K, Fukuda S, et al.

    The British journal of dermatology 2015; (173(1)):59-68 doi:10.1111/bjd.13711.

    PMID: 25640111
  6. 6

    A Case of Pemphigus Herpetiformis with Only Immunoglobulin G Anti-Desmocollin 3 Antibodies.

    Hong WJ, Hashimoto T, Kim SC

    Annals of dermatology 2016; (28(1)):102-6 doi:10.5021/ad.2016.28.1.102.

    PMID: 26848227
  7. 7

    Development of a Desmocollin-3 Active Mouse Model Recapitulating Human Atypical Pemphigus.

    Lotti R, Atene CG, Marconi A, et al.

    Frontiers in immunology 2019; (10()):1387 doi:10.3389/fimmu.2019.01387.

    PMID: 31275323
  8. 8

    Increased expression of in situ IL-31RA and circulating CXCL8 and CCL2 in pemphigus herpetiformis suggests participation of the IL-31 family in the pathogenesis of the disease.

    Morais KL, Miyamoto D, Orfali RL, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2020; (34(12)):2890-2897 doi:10.1111/jdv.16730.

    PMID: 32531145
  9. 9

    Clinical, pathologic, and immunologic features of pemphigus herpetiformis: a literature review and proposed diagnostic criteria.

    Costa LMC, Cappel MA, Keeling JH

    International journal of dermatology 2019; (58(9)):997-1007 doi:10.1111/ijd.14395.

    PMID: 30900757
  10. 10

    Bullous autoimmune dermatoses.

    Hofmann SC, Juratli HA, Eming R

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2018; (16(11)):1339-1358 doi:10.1111/ddg.13688.

    PMID: 30395395
  11. 11

    State-of-the-art diagnosis of autoimmune blistering diseases.

    van Beek N, Holtsche MM, Atefi I, et al.

    Frontiers in immunology 2024; (15()):1363032 doi:10.3389/fimmu.2024.1363032.

    PMID: 38903493
  12. 12

    Correlation between IL36α and IL17 and Activity of the Disease in Selected Autoimmune Blistering Diseases.

    Żebrowska A, Woźniacka A, Juczyńska K, et al.

    Mediators of inflammation 2017; (2017()):8980534 doi:10.1155/2017/8980534.

    PMID: 28611508
  13. 13

    Introducing human 3D skin models as a new serological diagnostic tool for severe autoimmune bullous diseases.

    Huth L, Heise R, Marquardt Y, et al.

    Frontiers in immunology 2025; (16()):1661851 doi:10.3389/fimmu.2025.1661851.

    PMID: 41080589
  14. 14

    Linear Immunoglobulin A (IgA) Bullous Dermatosis Mimicking Stevens-Johnson Syndrome.

    Park JS, Hamilton CD, Patel S, et al.

    Cureus 2022; (14(10)):e30309 doi:10.7759/cureus.30309.

    PMID: 36381872
  15. 15

    A Case of Pemphigus Herpetiformis in a 10-Year-Old Child.

    Hao Z, Fan L, Song H, Xiang Z

    Clinical, cosmetic and investigational dermatology 2026; (19()):605164 doi:10.2147/CCID.S605164.

    PMID: 42634662

This page is for informational purposes only and does not constitute medical advice. It explains pemphigus herpetiformis biology and testing; discuss your biopsy, antibody results, and treatment with your dermatologist or care team.

Get notified when new evidence is published on Herpetiform pemphigus.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.